Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
point decrease » point increase (Expand Search)
-
2841
-
2842
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
2843
-
2844
-
2845
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
2846
-
2847
-
2848
-
2849
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
2850
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
2851
-
2852
-
2853
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
2854
-
2855
-
2856
-
2857
-
2858
-
2859
-
2860